Founded with a mission to improve medication adherence, Intent Solutions, Inc. focuses on developing innovative medical devices tailored for clinical research, pain management, and specialized pharmacy. Their flagship product, tad™, ensures that medications are taken correctly by the right person at the right time, thereby enhancing patient outcomes and providing incremental insights into patient and trial participant behavior. The company primarily serves the United States market, aiming to reduce medication diversion and increase overall patient safety.

Notable figures associated with Intent Solutions include key industry experts and investors who have supported its growth and innovation. The company's achievements include the successful deployment of tad™ in various clinical settings, contributing to improved medication adherence and patient accountability. By addressing critical issues in medication management, Intent Solutions has made a significant impact on healthcare delivery, particularly in enhancing the safety and effectiveness of treatment protocols.